MedPath

Progentec Diagnostics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals

Conditions
Lupus Erythematosus
Lupus Erythematosus, Systemic
First Posted Date
2020-06-29
Last Posted Date
2020-06-29
Lead Sponsor
Progentec Diagnostics, Inc.
Target Recruit Count
300
Registration Number
NCT04449653
Locations
🇺🇸

Ryan Newhardt, Oklahoma City, Oklahoma, United States

Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic

Conditions
System; Lupus Erythematosus
SLE
Lupus Flare
Lupus Erythematosus
First Posted Date
2019-07-12
Last Posted Date
2020-09-16
Lead Sponsor
Progentec Diagnostics, Inc.
Target Recruit Count
60
Registration Number
NCT04018222
Locations
🇺🇸

IRIS Research and Development, Fort Lauderdale, Florida, United States

🇺🇸

Arthritis and Pain Associates of PG County, Greenbelt, Maryland, United States

🇺🇸

Altoona Center For Clinical Research, Duncansville, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.